Tags

Type your tag names separated by a space and hit enter

Pediculicide drug products for over-the-counter human use; amendment of final monograph. Final rule.
Fed Regist. 2003 Dec 31; 68(250):75414-8.FR

Abstract

The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph (FM) for over-the-counter (OTC) pediculicide drug products to revise labeling for the statement of identity, warnings, directions, and other required statements. Pediculicide drug products are used for the treatment of head, pubic (crab), and body lice. FDA is issuing this final rule as part of its ongoing review of OTC drug products after considering public comment on its proposed regulation and all relevant data and information that have come to the agency's attention.

Authors

No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

14986677

Citation

Food and Drug Administration, HHS. "Pediculicide Drug Products for Over-the-counter Human Use; Amendment of Final Monograph. Final Rule." Federal Register, vol. 68, no. 250, 2003, pp. 75414-8.
Food and Drug Administration, HHS. Pediculicide drug products for over-the-counter human use; amendment of final monograph. Final rule. Fed Regist. 2003;68(250):75414-8.
Food and Drug Administration, HHS. (2003). Pediculicide drug products for over-the-counter human use; amendment of final monograph. Final rule. Federal Register, 68(250), 75414-8.
Food and Drug Administration, HHS. Pediculicide Drug Products for Over-the-counter Human Use; Amendment of Final Monograph. Final Rule. Fed Regist. 2003 Dec 31;68(250):75414-8. PubMed PMID: 14986677.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Pediculicide drug products for over-the-counter human use; amendment of final monograph. Final rule. A1 - ,, PY - 2004/2/28/pubmed PY - 2004/3/12/medline PY - 2004/2/28/entrez SP - 75414 EP - 8 JF - Federal register JO - Fed Regist VL - 68 IS - 250 N2 - The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph (FM) for over-the-counter (OTC) pediculicide drug products to revise labeling for the statement of identity, warnings, directions, and other required statements. Pediculicide drug products are used for the treatment of head, pubic (crab), and body lice. FDA is issuing this final rule as part of its ongoing review of OTC drug products after considering public comment on its proposed regulation and all relevant data and information that have come to the agency's attention. SN - 0097-6326 UR - https://www.unboundmedicine.com/medline/citation/14986677/Pediculicide_drug_products_for_over_the_counter_human_use L2 - https://medlineplus.gov/overthecountermedicines.html DB - PRIME DP - Unbound Medicine ER -